Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA
Yuanjie Liu, Hui Nie, Richeng Mao, Bidisha Mitra, Dawei Cai, Ran Yan, Ju-Tao Guo, Timothy M. Block, Nadir Mechti and Haitao Guo
Published, Version of Record (VoR)CC BY V4.0, Open
Abstract
Life Sciences & Biomedicine Microbiology Parasitology Science & Technology Virology
Hepatitis B virus (HBV) replicates its DNA genome through reverse transcription of a viral RNA pregenome. We report herein that the interferon (IFN) stimulated exoribonuclease gene of 20 KD (ISG20) inhibits HBV replication through degradation of HBV RNA. ISG20 expression was observed at basal level and was highly upregulated upon IFN treatment in hepatocytes, and knock down of ISG20 resulted in elevation of HBV replication and attenuation of IFN-mediated antiviral effect. The sequence element conferring the susceptibility of HBV RNA to ISG20-mediated RNA degradation was mapped at the HBV RNA terminal redundant region containing epsilon (epsilon) stem-loop. Furthermore, ISG20-induced HBV RNA degradation relies on its ribonuclease activity, as the enzymatic inactive form ISG20(D94G) was unable to promote HBV RNA decay. Interestingly, ISG20(D94G) retained antiviral activity against HBV DNA replication by preventing pgRNA encapsidation, resulting from a consequence of ISG20-epsilon interaction. This interaction was further characterized by in vitro electrophoretic mobility shift assay (EMSA) and ISG20 was able to bind HBV epsilon directly in absence of any other cellular proteins, indicating a direct e RNA binding capability of ISG20; however, cofactor(s) may be required for ISG20 to efficiently degrade epsilon. In addition, the lower stem portion of epsilon is the major ISG20 binding site, and the removal of 4 base pairs from the bottom portion of epsilon abrogated the sensitivity of HBV RNA to ISG20, suggesting that the specificity of ISG20-epsilon interaction relies on both RNA structure and sequence. Furthermore, the C-terminal Exonuclease III (ExoIII) domain of ISG20 was determined to be responsible for interacting with epsilon, as the deletion of ExoIII abolished in vitro ISG20-epsilon binding and intracellular HBV RNA degradation. Taken together, our study sheds light on the underlying mechanisms of IFN-mediated HBV inhibition and the antiviral mechanism of ISG20 in general.
Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA
Creators
Yuanjie Liu - Indiana University
Hui Nie - Drexel University
Richeng Mao - Indiana University
Bidisha Mitra - Indiana University
Dawei Cai - Indiana University
Ran Yan - Indiana University
Ju-Tao Guo - Baruch S. Blumberg Institute
Timothy M. Block - Baruch S. Blumberg Institute
Nadir Mechti - University of Montpellier
Haitao Guo - Indiana University
Publication Details
PLoS pathogens, v 13(4), pp e1006296-e1006296
Publisher
Public Library Science
Number of pages
35
Grant note
R21AI103838; R01AI094474; R01AI110762 / National Institutes of Health of United States; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
R01AI113267 / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
Resource Type
Journal article
Language
English
Academic Unit
Microbiology and Immunology
Web of Science ID
WOS:000402555700014
Scopus ID
2-s2.0-85018304100
Other Identifier
991019169525104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: